scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.THROMRES.2016.01.004 |
P698 | PubMed publication ID | 26916299 |
P50 | author | John W. Eikelboom | Q42846212 |
Salim Yusuf | Q2214381 | ||
Lars Wallentin | Q6230815 | ||
Muredach P. Reilly | Q51505621 | ||
Alex C Spyropoulos | Q90710748 | ||
James Douketis | Q100404477 | ||
Jonas Oldgren | Q106086753 | ||
Michael D. Ezekowitz | Q110902282 | ||
Mandy Fraessdorf | Q114775432 | ||
P2093 | author name string | Stuart J Connolly | |
Martina Brueckmann | |||
Jeff S Healey | |||
P921 | main subject | (RS)-warfarin | Q407431 |
dabigatran | Q419345 | ||
P304 | page(s) | 77-81 | |
P577 | publication date | 2016-01-09 | |
P1433 | published in | Thrombosis Research | Q15758741 |
P1476 | title | Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial | |
P478 | volume | 139 |
Q47221597 | Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery. |
Q39129273 | Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation |
Q48149529 | Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery |
Q47654635 | Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. |
Q51007969 | Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study. |
Q92624903 | Idarucizumab for a traumatic head injury patient taking dabigatran |
Q50875752 | Managing direct oral anticoagulants in patients undergoing dentoalveolar surgery. |
Q64928648 | Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran. |
Q37680793 | Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases. |
Q48341889 | Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence. |
Q52603801 | Simultaneous Pancreas-Kidney Transplantation in a Patient with Heparin-Induced Thrombocytopenia on Dabigatran Therapy. |
Q28066262 | Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran |
Q38829586 | The discovery of dabigatran etexilate for the treatment of venous thrombosis |
Q48022060 | Update in perioperative medicine: practice changing evidence published in 2016. |
Search more.